TEMECULA, Calif., May 19, 2017 (GLOBE NEWSWIRE) — Holy Grail Company is proud to announce its official release of its new 300mg CBD additive. Following the foundation of the company, this new addition joins a long line of CBD vapor products. The new additive has a natural flavor like the 200mg offering on the market, however it contains no THC. Although it was originally designed to be added to any E-Liquid on the market, it can also be vaped as it is highly concentrated or even used under the tongue.
“The release of the 300mg came at the request of a new distribution partner. We believe it is important to listen to both our existing customers as well as our new customers to stay ahead of current trends in the market.” -Edward Quiroz, Co-CEO/Treasurer
“We feel that this new highly concentrated product will allow us to stay competitive and current within the marketplace. As the company stays focused on establishing roots in mainstream big-box stores with new brands, it will not lose sight of its core competencies. These initiatives are a key component to our continued success.” -Jason B Golec, Co-CEO/President
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Holy Grail Company/ Haenep’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. Holy Grail Company/ Haenep disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact Holy Grail Company/ Haenep’s forward-looking statements, please see Holy Grails/ Haenep’s filings on OTC Markets (OTC:HGRL).
For more information please visit us at: www.HolyGrailCompany.com